Glycogen branching enzyme deficiency

GBED disrupts the formation of glycogen, an energy store in cells

The body stores some glucose as glycogen so that energy remains available between meals. Glycogen is normally a structure with many branches, and an enzyme, a protein that enables a chemical reaction in cells, helps build those branches. GBE1 provides the instructions for this enzyme. The letters GBED stand for glycogen branching enzyme deficiency, describing the part of energy storage that is disrupted.

The known variant introduces an early stop in protein production. The resulting enzyme is not functional, so glycogen is poorly formed and abnormal material accumulates. Tissues relying on that reserve, including skeletal muscle, heart and brain, cannot maintain normal energy function. Biochemical and genetic studies established this mechanism and identified the DNA change used in targeted testing.

References [3] · [1]

GBED can cause pregnancy loss or severe weakness in a newborn foal

GBED can cause late pregnancy loss, stillbirth or severe illness in a newborn. Live-born affected foals may be weak, have poor muscle tone, struggle to stand and have a low body temperature. Seizures, breathing difficulty or heart failure may occur as different organs become affected. Not every foal displays every sign, and the initial presentation may resemble another neonatal illness.

The documented form is fatal: affected foals do not become healthy adults. A temporary improvement in their general condition does not correct the underlying energy-storage problem. Timing differs between cases, with some pregnancies ending before birth and some foals surviving weeks or a few months. This variation should not be mistaken for an adult form that can be managed in the same way as milder muscle disorders.

References [2] · [4] · [1]

An adult horse can carry the GBED variant without having GBED

The disease and variant are documented mainly in Quarter Horses, Paint Horses and related populations. A horse with one copy can work and breed without signs of GBED. That is how a recessive variant can remain unnoticed for generations: its presence in a parent need not be visible in its appearance, strength or day-to-day behaviour.

A breed name, discipline or ancestor does not provide an individual result. Published frequencies depend on which horses and lines were sampled, and cannot automatically describe every population in another country. Pedigree helps frame a question, while a test correctly linked to the horse establishes its status. Both prospective parents’ results matter when planning a mating.

References [1] · [4] · [3]

Weakness in a foal does not establish a diagnosis of GBED

A weak foal or one unable to nurse normally needs prompt veterinary assessment. Prematurity, infection, inadequate transfer of maternal antibodies and other diseases can produce similar signs. The veterinarian considers pregnancy and birth history, examination, blood findings and relevant ancestry. Suspecting GBED does not remove the need to assess other neonatal emergencies at the same time.

Blood tests may show low glucose or evidence of muscle and liver injury. Tissue examination can also provide clues, but is not always conclusive on its own. Targeted DNA testing is an important part of confirming this form. After pregnancy loss, suitable sampling and identification should be arranged with the veterinarian and laboratory so that the result answers the intended question.

References [2] · [3]

The GBED DNA test counts copies of the variant responsible for GBED

Testing targets the identified GBED variant, rather than whether the entire GBE1 gene is present. If no copy of the tested GBE1 variant is detected, the horse cannot pass that variant on. A horse with one copy is an unaffected GBED carrier. A foal with two copies, one inherited from each parent, has GBED. Inheritance is autosomal recessive, so both males and females can inherit the disease-causing combination.

A negative result does not exclude every other cause of neonatal weakness or pregnancy loss. Equally, finding one carrier parent does not prove GBED caused an earlier loss. The horse’s identity, the material analysed and the clinical or breeding question must be considered together. A genetic result explains a specific inherited status, not all the events in a reproductive history.

References [1] · [2] · [4]

What care is possible for a foal with GBED?

There is no curative treatment that restores the enzyme’s normal function in this equine form. Supportive care can address some consequences without removing the genetic defect. Prognosis is extremely poor. A veterinarian helps assess comfort, complications and decisions for a severely affected foal, rather than interpreting a short-lived improvement as evidence that the underlying disorder has resolved.

GBED and PSSM1 both involve glycogen, but they concern different genes, mechanisms and inheritance patterns. Management programmes for adult horses with PSSM1 are not treatments for GBED. It would also be misleading to suggest that a particular food or supplement can, on its own, reconstruct an absent or non-functional enzyme. The shared word glycogen does not make the diseases interchangeable.

References [2] · [4] · [3]

Testing both parents to prevent a foal with GBED

If the mare and stallion each have one copy of the GBE1 variant responsible for GBED, every conception has a 25% chance of affected offspring with two copies of that variant, a 50% chance of an unaffected carrier with one copy and a 25% chance of offspring without the variant. A two-copy conception may end in pregnancy loss, so these figures should not be treated simply as a distribution among live foals. Four pregnancies do not guarantee one outcome of each category.

A one-copy carrier bred to a horse without this variant cannot produce a two-copy offspring for this variant, although half the offspring on average may be carriers. This explains the value of testing both breeding animals. Probabilities apply afresh at each pregnancy: an earlier healthy foal does not alter the next chance. Future foal welfare and the population’s genetic diversity belong in the breeding discussion.

References [1] · [2] · [4]

Questions about the condition: Glycogen branching enzyme deficiency

Scientific sources about the condition: Glycogen branching enzyme deficiency

This article brings together the research and the university and laboratory resources listed below. Numbers after each section link to the references used. Sources consulted in November 2026.

1. 1.
   Glycogen Branching Enzyme Deficiency (GBED)

   UC Davis Veterinary Genetics Laboratory · Test documentation

2. 2.
   GBED: clinical signs, diagnosis and prognosis

   UC Davis Center for Equine Health · University resource

3. 3.
   Ward et al. (2004) — GBE1 mutation causing equine glycogen storage disease IV

   Mammalian Genome · Research

4. 4.
   GBED: genetic diagnostic testing

   Racing Australia — Equine Genetics Research Centre · Test documentation